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Abstract Increasing demand for genetic services has resulted
in the need to evaluate current service delivery models (SDMs)
and consider approaches that improve access to and efficiency
of genetic counseling (GC). This study aimed to describe
SDMs currently used by the GC community. The NSGC
membership was surveyed regarding the use of four SDMs:
in-person GC, telephone GC, group GC, and telegenetics GC.
Variables related to access and components of use were also
surveyed, including: appointment availability, time-per-
patient, number of patients seen, billing, and geographic
accessiblity. Seven hundred one usable responses were re-
ceived. Of these, 54.7 % reported using an in-person SDM
exclusively. The remainder (45.3 %) reported using multiple
SDMs. Telephone, group and telegenetics GC were used often
or always by 8.0 %, 3.2 % and 2.2 % of respondents, respec-
tively. Those using an in-person SDM reported the ability to
see the highest number of patients per week (p<0.0001) and
were the most likely to bill in some manner (p<0.0001). Those
using telegenetic and telephone GC served patients who lived
the furthest away, with 48.3 % and 35.8 %% respectively
providing GC to patients who live >4 h away. This study
shows that genetic counselors are incorporating SDMs other
than traditional in-person genetic counseling, and are utilizing
more than one model. These adaptations show a trend toward
shorter wait time and shorter length of appointments. Further
study is indicated to analyze benefits and limitations of each
individual model and factors influencing the choice to adopt
particular models into practice.
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Introduction
Traditionally, individuals with rare, Mendelian-inherited
disorders comprised the majority of medical genetics pa-
tients; however with the increase in understanding of the
genetics of common disease, referrals are expanding to the
general population. In anticipation of this expansion, there is
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a critical need to examine current genetic service delivery
models (SDM); evaluate and assess these models; determine
key components; and develop new, efficient, and effective
models for providing genetic services.
The National Society of Genetic Counselors (NSGC)
appointed the Service Delivery Model Task Force (SDMTF)
in 2009 as part of its 2010–2011 strategic initiatives. The
charge of the SDMTF was to research and assess the capacity
of all existing service delivery models to improve access to
genetic counseling (GC) in the context of increasing demand
for genetic testing and counseling services.
To evaluate service delivery models, the SDMTF pro-
posed definitions for current genetic counseling service
delivery models, modes of referral, and components of
service delivery (Cohen et al. 2012). It was proposed that
current models of service delivery can be defined by: 1) the
methods in which GC services are delivered (In-person,
Telephone, Group, and Telegenetics), 2) the way they are
accessed by patients (Traditional referral, Tandem, Triage,
Rescue, and Self -referral), and 3) the components unique to
each service setting (ex: documentation, specialty, physician
involvement, etc.). These definitions provide a starting point
whereby standardized terminology can be used in future
studies that assess the effectiveness of described models to
overcome barriers to access to GC services.
The traditional in-person model of providing genetic
counseling has been shown to involve an hour or longer of
clinic visit time and several hours of case preparation, doc-
umentation of the genetic counseling provided, and follow-
up (Wham et al. 2010; McPherson et al. 2008; Uhlmann et
al. 2009). This time intensive model is not well reimbursed
by third party payers and is not practical to reach a large
population (Tuckson 2006). Improvements in efficiency and
access are critical to ensuring that the growing number of
patients seeking genetic services receives appropriate care.
Measures of access include wait times (typically measured
in the time to the third next available appointment), travel
distance as defined by travel time from patient to service
location, and ability to get to be reimbursed for services (Hall
et al. 2008; Hyndman et al. 1999; Jones et al. 2003; McGrail
and Humphreys 2009).Wait times and distance traveled are of
particular concern for genetic counseling services since these
specialty services tend to be concentrated in academic centers
and large cities with relatively small workforces.
This study aims to describe the current landscape of GC
service delivery by surveying professional practice nation-
ally. Outcomes of genetic counseling in the context of these
different service delivery models will also need to be care-
fully considered. However, such subjects are beyond the
scope of this manuscript. To pave the way for this future
work, this manuscript focuses on the service delivery
models themselves. Ultimately, identification of the models
that effectively integrate and utilize genetic counselors in the
healthcare system will improve access to genetic counselors
and promote overall visibility of the profession.
Methods
Recruitment
Full members of the NSGC were notified of the study by e-
blast in September 2010 (N=2,316 genetic counselors as of
the first quarter of 2010). The study was also promoted in the
NSGC president’s weekly message and on the NSGC listserv.
Eligible participants included full members of NSGCwho had
provided clinical GC services during the preceding year. They
were invited to complete a Zoomerang™ multiple-choice
online survey of current SDM use.
Survey Instrument
The survey instrument was developed by the research team,
which includes individuals with diverse clinical genetics
backgrounds and work settings. The survey was piloted with
members of the NSGC Access and Service Delivery Com-
mittee and feedback was incorporated as appropriate. The
final survey included 51 questions, which included 48 mul-
tiple choice and rating scale questions, two open ended
questions, and one question asking for contact information
for future studies. The survey was converted into an online
format using Zoomerang™ software.
The survey instrument included a description of the four
major SDMs, including in-person (previously referred to as
face-to-face traditional), telephone, group, and telegenetic
GC per the definitions previously defined by the SDM
taskforce (Table 1) (Cohen et al. 2012). In-Person genetic
counseling involves cases where the patient is seen in-
person, typically within a healthcare facility of private of-
fice. Historically this has been referred to as “face-to-face”
however to accurately delineate from telegenetic counseling
utilizing video conferencing, the new up to date definition
was proposed. Telephone genetic counseling occurs when a
patient is provided genetic counseling for a new indication
or concern and the session is completed entirely via tele-
phone. Group genetic counseling involves multiple individ-
uals seen for genetic counseling together, usually for a
common indication. This model has been reported typically
occurring in-person in a health care setting or private office.
Telegenetic counseling has also been described as web-
based or videoconferencing genetic counseling. In this mod-
el genetic counseling is provided remotely via video-
conference or web-link, including visual and audio access.
The survey asked how often participants used these models
and all questions were asked in relation to new patients appoint-
ments, not return visits.Measures of access for eachmodel were
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assessed, including wait time, drive time from patient to GC
site, andmode of referral. Other measures of access assessed for
each model included billing practices, and the number of pa-
tients that could be seen by one full time genetic counselor per
week for each model used. Demographic information was
collected, including work setting, clinical specialty, number of
years of experience, certification, credentialing, and licensure
status. Willingness of the individual to participate in a future
interview analysis of service delivery was also determined.
Data Analysis
Use of each of the SDMs was analyzed separately in relation
to the measures of access (wait time to third next appointment
and drive time, number of new patients, referral method) and
components of the models (length of time in consultation,
limitations of scheduling, supervision and billing practices).
Cross tabulations and chi-square analyses for significance
were performed on the multiple-choice questions using Sta-
tistical Package for the Social Sciences (SPSS) software.
Open-ended comments to the survey were reviewed by the
authors for underlying themes. A formal qualitative analysis
of the open-ended responses was not performed.
This study was approved by the St. Vincent Hospital
Institutional Review Board (Indianapolis, IN) and the Uni-
versity of Michigan Medical Institutional Review Board
(Ann Arbor, MI).
Results
There were 820 respondents to the survey for an overall
response rate of 35.4 %. This is our best estimate, since not
all NSGC members may have received the e-blast or known
about the study invitation. Of the total respondents, 715 indi-
cated that they had provided clinical genetic counseling ser-
vices within the last year and, of these, 701 provided complete
responses that were used in data analysis. The demographic
data of respondents did not differ significantly from the de-
mographics of the respondents of the 2010 NSGC Profession-
al Status Survey (PSS) with regard to training, certifications,
specialty, and work setting. There were 21 respondents who
indicated theyworked outside of the United States of America.
As expected by the number of states that require licen-
sure, most genetic counselors responding to the survey were
not licensed (84.3 %) and most did not report being
credentialed by their institution (63 %) or payers (75.5 %).
Almost 17 % did not know their credentialing status. The
payer mix for clinical services in order of most to least
common was: private 3rd party payer, Medicaid, Medicare,
uninsured/out of pocket, integrated health care plan,
uninsured/charity care/grant support, socialized health care
(Supplemental Table A).
In-Person (Face-to-Face Traditional) Genetic Counseling
Overall, 95.7 % (671/701) of respondents indicated that they
have used in-person GC “always” (65.3 %) or “often” (30.4 %)
over the past 5 years. A breakdown of these responses for use of
service delivery model by specialty is presented in Table 2.
Wait time for most in-person appointments was less than
2 weeks. Sixty-five percent (65 %) of respondents indicated
that their third next available GC appointment for a new
patient was <1 week (35 %) or 1–2 weeks (30 %) (Table 3).
Stratifying by specialty, the prenatal specialty had the
highest response rate for appointments at <1 week (59 %)
Table 1 Definitions of service delivery models and referral patterns
Service Delivery Models (SDMs)
In-Person Genetic Counseling is provided in-person. Follow up and results disclosure may occur by telephone of other means
Telephone Genetic Counseling is provided remotely by telephone. The telephone call may be supplemented by written, online
or other resources.
Group Patients are educated in a group setting by a genetic counselor, which may be followed by individual assessment,
counseling etc. This model has been reported typically occurring in-person.
Telegenetic Genetic Counseling is provided remotely using videoconferencing
Referral Patterns
Traditional An MD or other health care provider recognizes an indication for genetic counseling and refers patient
Tandem A collaborative relationship in which the initial genetic counseling is done by another health care provider. Select patients
are then referred to a genetic counselor for follow up
Triage A collaborative relationship in which the initial genetic counseling is done by another health care provider. Select patients
are then referred to a genetic counselor as needed based on complexity
Rescue Healthcare providers refer select patients to genetic counselors in the absence of a collaborative relationship and after
they have encountered difficulty
Self-referred Referral initiated by a patient
Cohen et al. (2012)
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and 1–2 weeks (36 %). Pediatrics had the lowest response
rate for appointments at <1 week (8 %) and 1–2 weeks
(8 %). The remaining specialties (cancer, cardiac, general,
and other) had similar response rates with 1–2 weeks being
the most common (Table 3).
About one half of patients accessing in-person GC had less
than a 30-min drive (Table 3). Patients utilizing in-person GC
rarely had a 2–4 h drive or greater than 4 h drive. The number
of new patients one full time clinical genetic counselor could
see using in-person GC per week was reported to be 6–10 for
33 % of respondents, 11–15 for 23 % of respondents, and 16–
20 for 18 % of respondents (Table 3). This is similar to the
2010 PSS, with the average clinical genetic counselor
reporting 8.3 new patients per week. Referral patterns indicate
that most in-person genetic counseling sessions are initiated
by a healthcare provider (94.5 % always or often) in a tradi-
tional mode of referral (Table 3).
Seventy two percent (72 %) of respondents indicated that
they spent on average 31 to 60 min with patients for
in-person genetic counseling (Table 4). With regard to the
scheduling of new patients for in-person GC, only 19.4 %
indicated that they were “always” or “frequently” limited by
the availability of a procedure (ultrasound, amniocentesis,
etc). The largest reported limitation in scheduling was the
physician availability with 23.5 % reporting “always or
frequently” being limited by needing a physician under the
same roof, and 22.2 % reporting being limited by require-
ment for a physician available for part of the visit (Table 4).
Nearly half of respondents (49.4 %) definitively reported
billing for in-person GC services, and 31.1 % indicated that
they do not bill at all (Table 4). An additional 11.2 %
reported “other” strategies of billing and 8.4 % did not know
if they were billing. When billing for in-person GC services,
the most commonly used code was the 96040 GC code,
followed by consultation codes 99241–99245 or 99251–
99255 and evaluation and management codes 99201–
99205 or 99211–99215.
Telephone Counseling
It should be noted that upon review of the comments sec-
tions of this survey, some respondents appear to have
Table 2 Use of genetic counseling service delivery models
Overall usage In-person Telephone Group Telegenetics
Genetic Counselors reporting use
of this model “always” or “often”
95.7 % (671/701) 8.0 % (46/572) 3.2 % (19/593) 2.2 % (13/570)
By specialty In-person Telephone Group Telegenetics
Cancer 98.2 % (157/160) 3.9 % (6/153) 1.9 % (3/160) 1.3 % (2/160)
Cardiac 100.0 % (16/16) 6.2 % (1/16) −(0/16) −(0/16)
General genetics 90.2 % (37/41) 12.1 % (5/41) 4.9 % (2/41) 7.3 % (3/41)
Prenatal 99.0 % (200/202) 3.5 % (7/199) 3.0 % (6/202) 1.5 % (3/202)
Pediatrics 100 % (80/80) 6.9 % (5/72) −(0/80) 2.5 % (2/80)
Other 24.6 % (16/65) 24.6 % (16/65) 7.7 % (5/65) 1.5 % (1/65)
By years of experience In-person Telephone Group Telegenetics
<5 years 97.8 % (181/185) 4.8 % (9/185) −(0/185) 1.0 % (2/185)
5–10 years 96.6 % (175/181) 8.9 % (16/179) 3.0 % (6/181) 2.0 % (5/181)
11–15 years 94.3 % (67/71) 9.0 % (6/67) 5.0 % (4/71) 1.0 % (2/71)
>15 years 96.0 % (122/127) 8.0 % (10/125) 4.0 % (6/127) 2.0 % (3/127)
By work setting In-person Telephone Group Telegenetics
University Medical Center 97.5 % (240/246) 3.8 % (9/238) 1.0 % (3/246) 2.0 % (7/246)
Private hospital 98.3 % (121/123) 1.7 % (2/121) 2.0 % (3/123) −(0/123)
Public hospital 100 % (93/93) 3.3 % (3/92) 3.2 % (3/93) 2.1 % (2/93)
Diagnostic laboratory 72.7 % (8/11) 36.3 % (4/11) −(0/11) 18.1 % (2/11)
Integrated health plan 91.3 % (21/23) 43.4 % (10/22) 4.3 % (4/23) −(0/23)
Physicians private practice 97.5 % (39/40) 2.5 % (1/40) −(0/40) −(0/40)
Private practice 94.4 % (17/18) 16.7 % (3/18) −(0/18) −(0/18)
Government 100.0 % (8/8) −(0/8) 12.5 % (1/8) 25.0 % (2/8)
Not for profit organization 94.7 % (18/19) 15.8 % (3/19) −(0/19) −(0/19)
414 Cohen et al.
Table 3 Measures of access by service delivery model
Wait time to third next appointment
using this model
In-Person Telephone Group Telegenetics
Of Genetic Counselors who report any use of these models
< 1 week 34.9 % (204/584) 77.0 % (151/196) 21.3 % (17/80) 23.3 % (14/60)
-Cancer 22.1 % (35/158) 70.6 % (36/51) 7.4 % (2/27) 16.6 % (3/18)
-Cardiac 18.7 % (3/16) 55.5 % (5/9) −(0/3) −(0/1)
-General Genetics 21.0 % (8/38) 60.0 % (9/15) −(0/3) 12.5 % (1/8)
-Prenatal 59.4 % (120/202) 85.0 % (51/60) 38.5 %(10/26) 40.0 % (8/20)
-Pediatrics 7.5 % (6/80) 76.2 % (16/21) −(0/5) 10.0 % (1/10)
-Other 32.8 % (20/61) 86.5 % (32/37) 26.6 % (4/15) 25.0 % (1/4)
1–2 weeks 29.6 % (173/584) 12.7 % (25/196) 27.5 % (22/80) 25.0 % (15/60)
-Cancer 34.8 % (55/158) 17.6 % (9/51) 25.9 % (7/27) 33.3 % (6/18)
-Cardiac 25.0 % (4/16) −(0/9) −(0/3) −(0/1)
-General genetics 28.9 % (11/38) 20.0 % (3/15) 33.3 % (1/3) −(0/8)
-Prenatal 36.1 % (73/202) 11.6 % (7/60) 30.7 % (8/26) 50.0 % (10/20)
-Pediatrics 7.5 % (6/80) 14.2 % (3/21) 20.0 % (1/5) −(0/10)
-Other 26.2 % (16/61) 8.1 % (3/37) 33.3 % (5/15) −(0/4)
2–4 weeks 15.2 % (89/584) 6.1 % (12/196) 22.5 % (18/80) 20.0 % (12/60)
-Cancer 24.7 % (39/158) 5.8 % (3/51) 29.6 % (8/27) 22.2 % (4/18)
-Cardiac 25.0 % (4/16) 22.2 % (2/9) 66.6 % (2/3) −(0/1)
-General genetics 28.9 % (11/38) 20.0 % (3/15) −(0/3) 50.0 % (4/8)
-Prenatal 3.5 % (7/202) 1.6 % (1/60) 19.2 % (5/26) 5.0 % (1/20)
-Pediatrics 17.5 % (14/80) 9.5 % (2/21) 20.0 % (1/5) 30.0 % (3/10)
-Other 16.4 % (10/61) 2.7 % (1/37) 13.3 % (2/15) 25.0 % (1/4)
1–2 months 8.6 % (50/584) 1.5 % (3/196) 7.5 % (6/80) 15.0 % (9/60)
-Cancer 12.0 % (19/158) 1.9 % (1/51) 18.5 % (5/27) 16.6 % (3/18)
-Cardiac 6.25 % (1/16) 22.2 % (2/9) −(0/3) −(0/1)
-General genetics 10.5 % (4/38) −(0/15) −(0/3) 25.0 % (2/8)
-Prenatal −(0/202) −(0/60) −(0/26) −(0/20)
-Pediatrics 21.2 % (17/80) −(0/21) 20.0 % (1/5) 20.0 % (2/10)
-Other 11.5 % (7/61) −(0/37) −(0/15) 50.0 % (2/4)
>2 months 11.6 % (68/584) 2.5 % (5/196) 21.3 % (17/80) 16.7 % (10/60)
-Cancer 6.3 % (10/158) 3.9 % (2/51) 18.5 % (5/27) 11.1 % (2/18)
-Cardiac 25.0 % (4/16) −(0/9) 33.3 % (1/3) 100.0 % (1/1)
-General genetics 10.5 % (4/38) −(0/15) 66.6 % (2/3) 12.5 % (1/8)
-Prenatal 0.9 % (2/202) 1.6 % (1/60) 11.5 % (3/26) 5.0 % (1/20)
-Pediatrics 46.3 % (37/80) −(0/21) 40.0 % (2/5) 40.0 % (4/10)
-Other 13.1 % (8/61) 2.7 % (1/37) 26.6 % (4/15) −(0/4)
Drive time traveled for “most” or “all”
Traveled by patients using this model
In-Person Telephone Group Telegenetics
<30 min 49.2 %(282/573) 15.5 % (28/181) 59.2 % (45/76) 1.7 % (1/58)
30–60 min 33.4 % (191/571) 8.2 % (15/182) 30.2 % 23/76) 1.7 % (1/58)
1–2 h 8.2 % (46/558) 12.5 % (23/183) 10.5 % (8/76) 16.3 % (10/61)
2–4 h 4.9 % (27/549) 16.9 % (31/183) 5.4 % (4/74) 38.7 % (24/62)
>4 h 9.4 % (51/539) 35.8 % (66/184) 5.5 % (4/73) 48.3 % (29/60)
Number of new patients could be seen
per week using this model
In-Person Telephone Group Telegenetics
1–5 12.7 % (74/581) 27.9 % (55/197) 27.5 % (22/80) 53.2 % (33/62)
6–10 32.9 % (191/581) 10.1 % (20/197) 20.0 % (16/80) 9.7 % (6/62)
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interpreted the definition of telephone GC to include results
disclosure following an in-person visit, despite the defini-
tion provided that telephone counseling referred to a new
patient consultation completed by telephone. Twelve re-
sponses were removed as a result of a comment made either
in the telephone section (usually in the billing comments) or
at the end of the survey that telephone counseling is only
used to provide results. These 12 individuals removed from
the analysis included 3 who reported using the model “of-
ten” and 9 that reported using the model “rarely” (4) or
“sometimes” (5). After removing those 12 individuals, tele-
phone genetic counseling was reported to be in use by
41.3 % of respondents, and only 8.0 % reported “always”
or “often” using telephone genetic counseling (Table 2). The
average wait to the third next available appointment was
<1 week among 77.0 % of all respondents (Table 3). Pa-
tients accessing telephone GC showed a trend towards lon-
ger drive time, with a range of reported patient drive times
of 1–2 h, 2–4 h, and over 4 h. Of patients served using
telephone GC, the largest proportion served (35.8 %) lived
over a 4-h drive away. The most frequently reported number
of new patients that could be seen per week by one full time
clinical genetic counselor with telephone GC was 1–5
(27.9 %) and 6–10 (10.1 %); however, 43.6 % of respon-
dents reported uncertainty and did not report a range
(Table 3). A traditional mode of referral was the most
commonly reported for telephone GC (52.1 %), followed
by self-referral (29.0 %) (Table 3).
Average amount of time spent per patient in telephone
GC is less than 30 min (50.3 %), closely followed by 31–
60 min (45.6 %) (Table 4). The telephone SDM was not
highly limited by availability of a physician or support staff,
with the largest limitation reported being the number of
available genetic counselors (9.9 % reported this as “frequent-
ly” or “always” the limitation in arranging telephone GC). For
telephone GC, 84.8 % reported no requirements for physician
supervision (under the same roof or on the same telephone
call as services are delivered). Most genetic counselors
reported not billing for the telephone SDM (67.5 %). Only
7.5 % reported using some method of billing (Table 4).
Group Counseling
Only 16.8 % of respondents reported ever using group GC
and 3.2 % of genetic counselors responded that they use
group counseling “always” or “often” (Table 2).
The third next available appointment for group counsel-
ing ranged between <1 week and 4 weeks, with similar
responses for each of the time ranges therein (Table 3). A
wait time of 2–4 months was reported by 13.8 % of re-
spondents and 7.5 % had a wait time of greater than
4 months for group GC. Most or all patients who access
group GC live within a 30-min drive (59.2 %). Genetic
counselors who use group GC reported being able to see
between 1 and 5 patients per week (27.5 %) or 6–10 patients
per week (20 %). Patients accessed group GC most often
through a traditional mode of referral and least often through
a rescue mode (Table 3).
Most genetic counselors report spending less than
30 min in one-on-one counseling associated with a group
GC session (58.0 %) (Table 4). Time spent in the group
setting was not assessed. The most commonly reported
limitation in scheduling new patients for group GC was
physical space (reported by 19.2 % as “always” or “fre-
quently” a limitation) and the least common reported
limitation was lack of support staff (reported as “always”
Table 3 (continued)
Wait time to third next appointment
using this model
In-Person Telephone Group Telegenetics
Of Genetic Counselors who report any use of these models
11–15 22.7 % (132/581) 8.1 % (16/197) 10.0 % (8/80) 9.7 % (6/62)
16–20 18.4 % (107/581) 3.5 % (7/197) 8.8 % (7/80) 3.2 % (2/62)
21–30 10.5 % (61/581) 4.1 % (8/197) 8.8 % (7/80) 4.8 % (3/62)
>30 2.8 % (16/581) 2.5 % (5/197) 3.8 % (3/80) −(0/62)
Not sure −(0/581) 43.6 % (86/197) 21.3 % (17/80) 19.4 % (12/62)
Referral method reported “always”
or “often” in this model
In-Person Telephone Group Telegenetics
Traditional 94.5 % (550/582) 52.1 % (99/190) 75.3 % (58/77) 82.0 % (50/61)
Tandem 3.0 % (17/555) 6.0 % (11/182) 7.9 % (6/76) 5.0 % (3/59)
Triage 3.8 % (21/556) 5.7 % (10/179) 1.3 % (1/75) 5.0 % (3/59)
Rescue 8.0 % (44/556) 9.3 % (17/182) −(0/75) 10.0 % (6/60)
Self-referred 9.1 % (52/571) 29.0 % (54/186) 28.6 % (2/77) 10.0 % (6/60)
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or “frequently” a barrier by 7.7 %). Most genetic coun-
selors reported that they had no physician supervision
requirements when counseling new patients by group GC
(55.1 %), although 17.2 % reported needing to have a
physician readily available under the same roof and
14.9 % reported that a physician needed to be in the room
for part of the visit (Table 4).
Although many genetic counselors reported not billing
for their services (41.0 %), 26.9 % of genetic counselors
report some form of billing for group GC services
(Table 4). An additional 21.8 % reported “other” strate-
gies of billing and 10.3 % did not know if they were
billing. When billing for group GC services, the most
commonly used code was the 96040 GC code, followed
Table 4 Components of service delivery model use
Average time spent in consultation using this model In-Person Telephone Group Telegenetics
None −(0/582) −(0/195) 8.0 % (6/77) −(0/62)
< 30 min 6.0 % (35/582) 50.2 % (98/195) 58.0 % (45/77) 12.0 % (7/62)
31–60 min 72.0 % (395/582) 45.6 % (89/195) 17.0 % (13/77) 77.0 % (46/62)
61–90 min 20.0 % (110/582) 3.6 % (7/195) 14.0 % (11/77) 12.0 % (7/62)
> 90 min 1.0 % (7/582) 0.5 % (1/195) 3.0 % (2/77) −(0/62)
Limitations in scheduling reported “always”
or “frequently” using this model
In-Person Telephone Group Telegenetics Remote
site = R
GC site = H
Procedure 19.4 % (110/569) NA 10.3 % (8/78) NA
Physician under same roof 23.5 % (136/578) 2.6 % (5/192) 14.1 % (11/78) 11.7 % (7/60)
Physician for part of visit 22.2 % (127/573) 0.5 % (1/191) 15.6 % (12/77) 13.3 % (8/60)
# Clinical GC’s 17.8 % (103/576) 9.9 % (19/191) 17.9 % (14/78) 16.7 % (10/60)
Support Staff 6.8 % (39/573) 2.6 % (5/191) 7.7 % (6/78) R 25.8 % (16/62)
H 12.9 % (8/62)
Physical space 12.6 % (73/578) N/A 19.2 % (15/78) R 24.2 % (15/62)
H 25.0 % (15/60)
Requirement for Physician supervision in this model? In-Person Telephone Group Telegenetics
No 39.3 % (242/615) 84.8 % (168/198) 55.1 % (48/87) 59.0 % (36/61)
Yes, in room/on phone 0.4 % (3/615) 0.4 % (1/198) 1.1 % (1/87) 4.9 % (3/61)
Yes for physical exam 10.7 % (66/615) N/A 5.7 % (5/87) 4.9 % (3/61)
Yes, for part of visit 19.3 % (119/615) −(0/198) 14.9 % (13/87) 11.4 % (7/61)
MD Readily available 21.9 % (135/615) 6.1 % (12/198) 17.2 % (15/87) 9.8 % (6/61)
Other 8.1 % (50/615) 8.5 % (17/198) 5.7 % (5/87) 9.8 % (6/61)
Billing methods used in this model In-Person Telephone Group Telegenetics
In GC’s name and NPI 8.6 % (50/582) 3.5 % (7/200) 5.1 % (4/78) 1.6 % (1/63)
Incident to Physician 24.1 % (140/582) 1.5 % (3/200) 15.4 % (12/78) 11.1 % (7/63)
Facility Fee 11.0 % (64/582) 0.5 % (1/200) 5.1 % (4/78) −(0/63)
Bundled Charge 5.7 % (33/582) 2.0 % (4/200) 1.3 % (1/78) 4.8 % (3/63)
No Billing 31.1 % (181/582) 67.5 % (135/200) 41.0 % (32/78) 47.6 % (30/63)
Do Not know 8.4 % (49/582) 8.5 % (17/200) 10.3 % (8/78) 12.7 % (8/63)
Other 11.2 % (65/582) 16.5 % (36/200) 21.8 % (17/78) 22.2 % (14/63)
Billing Codes used in this model In-Person Telephone Group Telegenetics
CPT 96040 27.4 % (158/576) 3.6 % (7/193) 13.3 % (10/75) 8.2 % (5/61)
HCPS S0265 0.2 % (1/576) −(0/193) −(0/75) −(0/61)
CPT E&M Codes (99201–99205,99211–99215) 9.2 % (53/576) −(0/193) 6.7 % (5/75) −(0/61)
CPT Consultation Codes (99241–99245, 99251–99255) 16.0 % (92/576) 1.0 % (2/193) 9.3 % (7/75) 8.2 % (5/61)
Other CPT Codes −(0/576) 9.8 % (19/193) 4.0 % (3/75) −(0/61)
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by consultation codes 99241–99245 or 99251–99255 and
evaluation and management codes 99201–99205 or
99211–99215.
Telegenetic Counseling
Overall, genetic counselors in this survey used the
telegenetic model least frequently (2.2 % reported using this
“often;” none reported using it “always”). Most genetic
counselors (88 %) reported never using this model (Table 2).
The third next available appointment for telegenetic
counseling ranged between <1 week to over 2 months
(Table 3). A wait time of less than 4 weeks was reported by
more than two thirds of respondents (68.3 %). The frequency
of accessing telegenetic genetic counseling is directly propor-
tional to the patient drive time, with 87.0 % of patients living
over 2 h away from the GC location (Table 3). Most genetic
counselors reported the ability to see 1–5 new patients per
week with telegenetic counseling. Patients access telegenetic
counseling most often through a traditional mode of referral
and least often through a tandem or triage mode (Table 3).
During the telegenetics appointment, most genetic coun-
selors reported spending an average of 30–60 min (77.0 %)
(Table 4). Most genetic counselors reported that a physician
was never required to be under the same roof for a
telegenetic consultation (59.0 %). Only 11.7 % reported that
a physician “always “or “frequently”was required to be under
the same roof and 13.3 % reported that the availability of a
physician for part of the visit was “always” or “frequently” a
limitation in scheduling new patients (Table 4). The most
often reported limitations for the telegenetic model were sup-
port staff at the remote site (25.8 %) and physical space at both
the host (25.0 %) and remote location (24.2 %) (Table 4).
Only 17.5 % of genetic counselors report some form of
billing for telegenetic services, while many genetic counselors
reported not billing for their services (47.6 %) (Table 4). An
additional 22.2 % reported “other” strategies of billing and
12.7 % did not know if they were billing. When billing for
telegenetic services, the only codes reported to be used were
the 96040 GC code and consultation codes 99241–99245.
General Comparisons
Almost half of genetic counselors surveyed (43.4 %) use more
than one SDM. Of those who use one SDM exclusively
(54.7 %), 98 % (383/391) use the in-person SDM exclusively
and 2 % (8/391) use the telephone SDM exclusively . The
longer a genetic counselor has been in the profession, the more
likely they are to use more than one SDMs (p=0.024), al-
though there was no statistically significant difference for any
of the models in years experience and use of each model.
Certified genetic counselors are significantly more likely to
use multiple SDMs or SDMs other than in-person (p=0.001).
Comparison analysis of use of SDMs by specialty and
work setting was performed; however sample size for SDMs
other than in-person GC limited the ability to assess for
significance. Trends in data, however, were noted. Cardiac,
cancer and prenatal genetic counselors and those who work
in a diagnostic laboratory or an integrated health plan
appeared more likely to use multiple SDMs than those
who work in a university medical center or private practice
setting (Table 2). Genetic counselors working for diagnostic
laboratories and integrated health plans reported the highest
proportional use of telephone GC.
In-person GC was the most utilized model, and estimated
capacity to see new patients per week per full time genetic
counselor was also highest in this model, compared to other
SDMs (p<0.0001) (Table 3). Genetic counselors using
telegenetic and telephone SDMs report a significantly longer
drive time from patient to GC location compared to those who
use in-person or group counseling (p<0.0001) (Table 3). Time
spent in consultation using the telephone SDMwas significant-
ly shorter than reported in other models (p<0.0001) (Table 4).
Referral patterns indicate that most GC sessions, regard-
less of SDM, are initiated by a health care provider using a
traditional mode of referral. Self-referral, the second most
commonly reported mode, was reported most frequently for
group and telephone SDMs (Table 3).
Discussion
As expected, in-person GC is the model used most often by
respondents. However, almost half of genetic counselors re-
port using more than one SDM. This suggests that genetic
counselors are expanding the way in which they provide
services, presumably to improve access and/or efficiency. This
will require further study, and genetic counselors who indicat-
ed they would be willing to answer more specific questions
will be contacted as part of another study tomore fully explore
their use of SDMs, what led them to use different SDMs and
nuances of the models they have chosen.
The overall frequency of genetic counselors reporting use
of telegenetics is low, likely due to the fact that the technology
is fairly new, and equipment may be expensive or inaccessi-
ble. Interestingly, genetic counselors working for government
agencies and diagnostic laboratories reported the greatest use
of telegenetic counseling. Further investigation is needed to
confirm and explore why this less traditional model is selected
more often within these settings.
Past literature describes long wait times to access genetic
services (McPherson et al. 2008). Wham et al. report that
46 % of cancer genetic counselors surveyed had a wait time
of 3 weeks or longer (Wham et al. 2010). In contrast, this
survey found that 57 % of cancer genetic counselors who
provide in-person genetic counseling reported a wait time of
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less than 2 weeks (Table 3). This is a vast improvement over
past reports, and may reflect a trend of improved access. The
study was not able to ascertain why these wait times are less
than previous studies reported, and it may be worthwhile to
investigate what components of service delivery contributed
to these improvements. With regard to in-person genetic
counseling in our data set, prenatal genetic counselors
reported the shortest wait time, with 95 % reporting that
their 3rd next available appointment is in less than 2 weeks
(Table 3). Similar to cancer genetic counselors, 43 %–59 %
of general, cardiac and other specialty genetic counselors
reported their 3rd next available appointment within 2 weeks
(Table 3). In contrast, pediatric genetic counselors reported
the longest wait time with 46 % reporting a wait time over
2 months. Given that pediatric genetic counselors are the
specialty most often working in collaboration with board
certified geneticists, a limited resource, these extended wait
times are not surprising. This study demonstrates adaptations
across other specialties that can inform efforts to improve
wait times in the pediatric genetic counseling specialty.
The number of patients seen per week was the highest
among genetic counselors providing in-person GC. Since
the time spent per patient was reported as the shortest with
telephone GC, this is somewhat surprising. Participants
were asked to estimate the number of patients one full time
genetic counselor could see per week by each model. It is
possible that respondents may have been misinterpreted this
question to mean “how many DO you see” versus “how
many CAN you see”. Additionally, there may be an inability
for genetic counselors to estimate how many patients could
be seen with one particular model, since they were often
using more than one different model in practice. These
comparisons included a “not sure” response, which was
“0” among genetic counselors providing in-person genetic
counseling, but 43.7 % among genetic counselors who
provided telephone genetic counseling. This suggests that
genetic counselors have difficult estimating a model that
they perhaps don’t use as often. Limiting analysis to just
the 12 genetic counselors who reported using telephone
counseling “always”, none were unable to estimate number
of patients that could be seen per week, suggesting that
experience allows for a better estimate. Of these, 27.3 %
reported being able to see 11–15 patients per week, and
18.2 % reported being able to see >30, 21–30, 16–20 and
6–10 patients each. Although these numbers are small, they
do suggest that telephone counseling may be able to reach a
larger number of patients and that a targeted survey of
genetic counselors using this model solely may provide
further data.
The time spent in a genetic counseling session reported in
this survey was also substantially less than reported in past
publications. Most genetic counselors using in-person GC
reported spending 31–60 min in consultation. In this survey,
58.2 % of cancer genetic counselors reported spending less
than or equal to 60 min in consultation, compared to 46.3 %
of cancer genetic counselors who reported spending less
than or equal to 60 min in 2008 (Wham et al. 2010).
Therefore, in just 2 years, there appears to be a trend toward
shorter in-person consultations, possibly an indication of a
step toward greater efficiency. It is important to note that the
type and complexity of a genetic counseling visit likely has
implications to the time spent in a genetic counseling ses-
sion. This survey specified that responses should reflect
new-patient visits only, however complexity can vary de-
pendent upon diagnosis. While the ability to assess visit
complexity was not within the scope of this study, the
planned follow-up study utilizing interviews of willing re-
spondents may allow for further analysis.
The telegenetic and telephone SDMs appear to fill a need
for improved access for patients who live far away from a
genetics provider, as the drive times from patient to GC site
are significantly longer for genetic counselors who use
either of these models. The telegenetics model users
reported a longer average wait time for scheduling than for
the other models, possibly due to the reported limitations of
physical space and support staff. Specifics on equipment
used for telegenetics services was not collected, and may
contribute to this difference in wait times and issues with the
physical space limitations.
It was interesting to note that most patients accessing
group genetic counseling had less than a 30-min drive.
Although the numbers are small, this suggests that group
genetic counseling is not used to improve distance access,
but may be used in an attempt to improve efficiency and
shorten consultation time, as previously documented (Calzone
et al. 2005).
Continued efforts to improve billing for the reimburse-
ment for services provided by genetic counselors are critical
to the sustainability of any service delivery model. Respon-
dents using in-person GC were most likely to bill. For those
genetic counselors who did report billing for services, most
reported billing for physician time only. This may reflect
institution-specific billing structures and may dictate, in
some cases, the involvement of a physician in the consulta-
tion. Over 2/3 of those using telephone GC, and almost half
of those using group or telegenetic counseling reported not
billing for this service. These models were most often in use in
laboratories, integrated health plans and government agencies.
It may be that these institutions calculate downstream costs to
fund these services, or that the genetic counseling service is
part of a grant, or contracted service price; however this is
speculative, as this data was not obtained within the scope of
this study.
Individual members of the NSGC were asked to respond
on their personal use of the four currently defined service
delivery models; in-person, group, telephone and telegenetic
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counseling. Participants were not selected by state, location
or institution. It is possible that this may have resulted in
multiple respondents from the same center or institution.
While this may have resulted in similar responses to the
survey questions, it is felt that isolating respondents to only
one or two genetic counselors per center would not allow for
proper representation of use as even within individual cen-
ters, the choices and use of a service delivery model can
vary between specialty clinics. Additionally, opening up the
survey to the entire membership resulted in a better repre-
sentative sampling of the population of currently practicing
genetic counselors.
Data regarding use of telephone GC should be interpreted
cautiously. Again, it became clear upon review of the com-
ment section at the end of the survey that some participants
had interpreted the definition of telephone GC to include
results disclosure following an in-person visit, contrary to
the definition provided in the survey. Although we did
remove 12 individuals from the analysis who specifically
mentioned using telephone GC only for providing results, it
is possible that others interpreted this incorrectly but did not
comment. This particular confusion stresses the need for
clear definition and language when discussing SDM, which
has been attempted in a prior publication from this group
(Cohen et al. 2012). We suspect that the use of telephone
GC as a primary SDM may be lower than reported here,
however recent literature is demonstrating increased use and
acceptance of telephone genetic counseling (Bradbury et al.
2011; Doughty Rice et al. 2010; Graves et al. 2010; Shanley
et al. 2007; Sutphen et al. 2010).
Conclusions
These data demonstrate that many genetic counselors are
incorporating models other than traditional in-person GC
and that these newer models are reaching patients who live
at greater distances from GC locations and are associated
with shorter wait times, improving the efficiency of genetic
counseling services. Each practice setting and specialty will
likely have unique needs, thus the determination of which
SDM(s) best fit a given organization or practice may vary.
Additionally, the ability to sustain any of these models will
be dependent on improved billing and reimbursement for
these services. Approximately half (50 %) of respondents
using each of the models were not billing or were unsure of
how they were billing. This trend has been recognized in
previous study (Harrison et al. 2010) and has led to multiple
NSGC initiatives to increase genetic counselor education
and awareness of billing issues. This data affirms the need
for these programs as well as ongoing local and national
initiatives to improve professional recognition and reim-
bursement for GC services.
This study provides an overview of the SDMs currently
used by genetic counselors to deliver GC services and pro-
vides insight into how they impact access. These data pro-
vide the foundation for further exploring the nuances of
each SDM considered when adopting a model for use and
the components that allow for improved access, increased
efficiency, and sustainability. More analysis is necessary to
identify individual best practices, limitations, barriers and
benefits of each model. Furthermore, as the landscape of
genetic counseling service delivery evolves, additional re-
search is needed to assure that all SDMs provide similar
quality of care and patient outcomes.
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